Oracle | GenomeWeb

Oracle

As a silver member, N-of-One's clinical interpretation solutions will be integrated with Oracle infrastructure to support precision medicine.

NEW YORK (GenomeWeb) – Oracle said this week that Erasmus University Medical Center Rotterdam has selected the Oracle Health Sciences Translational Research Center and the Oracle Exadata Database Machine to support research projects focused on personalized medicine and better patient outcomes.

Andrew Morris has joined SQI Diagnostics' board of directors.

NEW YORK (GenomeWeb News) – The Oracle Health Sciences Network today announced the inclusion of Genetic Alliance into the network, creating a bridge "linking individuals in its crowd-sourced patient registry to clinical trials."

Increasing activity from sequencing vendors and other new players, as well as a flurry of activity around clinical data analysis software and the commercialization of a number of open source tools were the key trends in the bioinformatics community in 2012.

NEW YORK (GenomeWeb News) – The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium announced today that Oracle Health Sciences has joined the consortium.

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

The University of Pittsburgh Medical Center said this week that it plans to invest $100 million over five years in informatics infrastructure, training, and support aimed at making personalized medicine a reality.

NEW YORK (GenomeWeb News) – Non-profit health system UPMC today announced a five-year $100 million investment to establish an enterprise analytics initiative to foster personalized medicine.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.